16
"Dr. Hansen, sorry to bother you." Valerie stood at the doorway, speaking softly.
Dr. Hansen looked up and saw Valerie, a faint smile appearing on her face. "Miss Valerie, please come in. Just in time, I've just finished a set of preliminary observations."
Valerie walked into the laboratory, her gaze sweeping over the crude equipment. As Dr. Hansen had mentioned before, the conditions here were indeed quite basic.
"I hope I'm not interrupting your important work," Valerie said.
"Not at all. Just basic observations," Dr. Hansen straightened up, rubbing her slightly sore neck. "The activity of these spores is already very low; they struggle to survive once the environment changes.
What is truly valuable are the live samples, but the hyperion lacks safe conditions for live cultivation."
There was a clear sense of regret in her tone.
Valerie nodded and handed over the data pad in her hand.
"Doctor, this is what I mentioned earlier—a summary of some Biotechnica methods used internally by our company. It has been desensitized and does not involve core patents, but perhaps it can provide a different perspective for your research."
Dr. Hansen's eyes lit up immediately. She took the data pad almost eagerly, quickly woke up the screen, and began to browse.
At first, her expression was one of focused review, but as she read deeper, her brows furrowed and smoothed out, and occasionally she would mutter a few words to herself.
"This gene sequence alignment algorithm—it uses multiple fuzzy matching and probability weighting? The approach is very unique, completely different from the precise chain alignment commonly used in the Koprulu Sector.
It sacrifices a certain degree of absolute precision but gains higher fault tolerance and recognition speed for highly mutated sequences—interesting."
"Protein folding simulation—introducing environmental charge gradients as auxiliary parameters? This is usually discarded as noise in our general models.
But thinking about it carefully, the intracellular environment is indeed not homogeneous—this is a very bold hypothesis."
"Nanofiber scaffolds—using electrospinning technology to create bionic extracellular matrices? The material selection is—a composite of synthetic polyester and natural gelatin? How was the balance point between the mechanical strength and biocompatibility of this combination found?"
Dr. Hansen was completely immersed in the technical documentation, sometimes quickly scrolling through pages, sometimes stopping to think carefully.
Her two assistants also curiously leaned in to watch, letting out low exclamations.
Valerie stood quietly to the side, observing Dr. Hansen's reaction.
This female scientist clearly possessed extremely high professional competence, able to quickly grasp the principles and potential value of these technologies, and immediately compare and question them against the systems she knew.
About twenty minutes later, Dr. Hansen finally looked up from the data pad and let out a long sigh.
Her face wore an expression mixed with excitement, confusion, and deep thought.
"Miss Valerie," her voice was somewhat excited, "these technical approaches—are very novel. No, not just novel, they have significant differences from the mainstream Biotechnica in our Koprulu Sector in terms of basic assumptions and methodology."
She pointed to a chart on the data pad: "For example, this rapid gene sequencing algorithm seems to be based on a completely different mathematical and logical framework. We here focus more on 'correctness,' where every step must be verifiable and repeatable.
And your method—it's more like 'finding the most probable' within possibilities, allowing for a certain degree of fuzziness and uncertainty in exchange for speed. This requires extremely powerful data processing capabilities as support."
She pointed to another section: "And this cell culture scaffold, the way material science and bioengineering are combined is also very unique. We tend to use pure biological materials or highly refined synthetic materials to ensure absolute control.
Your composite material scheme looks rough, but the design concept is to simulate the heterogeneous characteristics of natural tissues—this requires very fine process control and a deep understanding of the biological micro-environment."
Dr. Hansen put down the data pad and looked at Valerie with burning eyes: "These are not just some 'practical technologies.' Behind this represents a different research paradigm.
Has the Biotechnica of the Earth Sphere developed to this extent already? Or is this a research achievement unique to the 'Far Star Union'?"
Valerie maintained a calm smile.
"Doctor, you flatter me. These are just some phased results from our company's R&D department, far from representing the technological level of the Earth Sphere. As you said, the two sectors have been isolated for too long and have developed different technological paths.
Our methods might be effective in certain specific scenarios, but in other aspects, the solid, practical technology of the Koprulu Sector might have more advantages."
She cleverly avoided answering directly about the overall level of the Earth Sphere and pulled the focus back to the technology itself. "Are these materials helpful to your research?"
"Very helpful!" Dr. Hansen said affirmatively, "They provide entirely new ideas. Especially regarding research ideas for dealing with highly mutated organisms. The genetic stability of The Swarm is extremely poor, and its mutation speed is fast; our traditional analytical methods often encounter difficulties.
Your alignment algorithm with higher fault tolerance might be better at processing the genetic data of The Swarm samples."
She paused, her tone becoming a bit hesitant, but more filled with longing: "Miss Valerie, do these technologies—have more detailed implementation details or experimental data? Of course, I understand this involves trade secrets.
But if possible, even just a small portion of more in-depth information would be a huge boost to my research. I can sign any non-disclosure agreement."
Valerie's heart stirred. Dr. Hansen had already shown strong interest and a desire for further understanding. This was a good opportunity to establish a closer connection.
"More detailed materials do require higher-level authorization." Valerie showed a slightly troubled but willing-to-try expression, "However, your research makes a direct contribution to fighting The Swarm, which aligns with our company's 'risk mitigation and cooperation' principles.
I can try to apply to headquarters to retrieve some non-core extended materials or case studies.
But this will take time, and it also requires—a clearer framework for cooperation."
Dr. Hansen nodded immediately.
"I understand. I am willing to seriously consider any form of cooperation. If your company is interested in Swarm research, I can share some of my research results—of course, not involving the core secrets I worked on for the Empire in the past. We can conduct technical exchanges and complement each other's strengths."
This was exactly the situation Valerie hoped to achieve.
"I will report your intentions to headquarters as soon as possible, Doctor. I believe the senior management will be interested in cooperating with an expert like you."
